These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18384629)

  • 1. DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.
    Ma X; Xu H; Zheng T; Li HZ; Shi TP; Wang BJ; Ju ZH; Wang C; Zhang GX; Zhang X
    BJU Int; 2008 Aug; 102(5):633-6. PubMed ID: 18384629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
    Liang J; Li Y; Wang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.
    Kiemeney LA; van Houwelingen KP; Bogaerts M; Witjes JA; Swinkels DW; den Heijer M; Franke B; Schalken JA; Verhaegh GW
    Eur J Cancer; 2006 Dec; 42(18):3219-27. PubMed ID: 16934975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population.
    Yamada H; Shinmura K; Ikeda S; Tao H; Otani T; Hanaoka T; Tsuneyoshi T; Tsugane S; Sugimura H
    Scand J Gastroenterol; 2007 Dec; 42(12):1479-85. PubMed ID: 17852867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between a C/A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder.
    Zhang X; Ma X; Zhu QG; Li LC; Chen Z; Ye ZQ
    J Urol; 2003 Oct; 170(4 Pt 1):1379-82. PubMed ID: 14501773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4 gene intron-3 polymorphism is associated with transitional cell carcinoma of the urinary bladder.
    Tsai FJ; Chang CH; Chen CC; Hsia TC; Chen HY; Chen WC
    BJU Int; 2005 Feb; 95(3):432-5. PubMed ID: 15679809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
    Bid HK; Manchanda PK; Mittal RD
    Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
    BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
    Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
    Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.
    Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T
    J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
    Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
    Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDH1 C-160A promoter polymorphism and gastric cancer risk.
    Corso G; Berardi A; Marrelli D; Pedrazzani C; Garosi L; Pinto E; Roviello F
    Eur J Cancer Prev; 2009 Feb; 18(1):46-9. PubMed ID: 19077564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1).
    Narter KF; Ergen A; Agaçhan B; Görmüs U; Timirci O; Isbir T
    Anticancer Res; 2009 Apr; 29(4):1389-93. PubMed ID: 19414392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case-control study on JWA promoter -76G-->C polymorphism and the susceptibility of bladder cancer].
    Wu W; Li CP; Chen R; Cao XJ; Li AP; Wang Y; Yang KH; Qian LX; Liu QZ; Li ZL; Zhou JW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):648-52. PubMed ID: 16331563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
    Humar B; Graziano F; Cascinu S; Catalano V; Ruzzo AM; Magnani M; Toro T; Burchill T; Futschik ME; Merriman T; Guilford P
    Oncogene; 2002 Nov; 21(53):8192-5. PubMed ID: 12444556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population.
    Mittal RD; Manchanda PK; Bhat S; Bid HK
    BJU Int; 2007 Apr; 99(4):933-7. PubMed ID: 17378851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy.
    Ahirwar DK; Mandhani A; Dharaskar A; Kesarwani P; Mittal RD
    BJU Int; 2009 Sep; 104(6):867-73. PubMed ID: 19338536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.